Controlled Substance Monitoring and Drugs of Abuse Testing
JH · Effective Oct 1, 2015
21 active Medicare policies list F43.10, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
5 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of F43.10 |
|---|---|---|
| Actigraphy and Accelerometry | Oct 3, 2023 | Covered |
| Electrical Stimulation for Nausea, Vomiting, Motion Sickness and Other Selected Indications | Jan 5, 2024 | Covered |
| Evoked Potential Studies | Oct 25, 2023 | Covered |
| Eye Movement Desensitization and Reprocessing (EMDR) Therapy | Sep 7, 2023 | Covered |
| Quantitative EEG (Brain Mapping) | Apr 25, 2023 | Covered |
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JL · Effective Oct 1, 2024
National · Effective Nov 6, 2025
JL · Effective Oct 1, 2025
J9 · Effective Jan 1, 2025
National · Effective Mar 26, 2026
J6 · Effective Jan 1, 2026
J5 · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
J6 · Effective Oct 1, 2024